Do Statins Cause Tendon Problems? What the Evidence Shows
- Mar 4
- 3 min read
Updated: 4 days ago
By Dr. Jeffrey Peng, MD · Updated August 2026
Watch the Full Video
If you take a statin for cholesterol, you may have wondered whether it is connected to tendon pain. For years the evidence was mixed. A large nationwide cohort study now provides some of the strongest data to date: statin use is associated with a significantly higher risk of tendinopathy.
Here is what the study found, which statins carry the highest risk, how the risk changes over time, and practical steps you can take to protect your tendons.
What the Research Shows
A 2023 nationwide population-based cohort study by Kwak et al. analyzed more than 84,000 statin users matched against 168,000 controls. The researchers tracked five common tendinopathies: trigger finger, De Quervain’s tenosynovitis, tennis and golfer’s elbow, rotator cuff tendinopathy, and Achilles tendinitis.
Statin users had a 43.5% higher risk of developing tendinopathy (hazard ratio 1.435). In absolute terms this translated to roughly 10 additional cases per 10,000 person-years — a meaningful but modest increase that must be weighed against the cardiovascular benefits of statin therapy.
Which Statins Carry the Highest Risk?
Atorvastatin and simvastatin showed the highest rates of tendinopathy across the tendon types examined. Rosuvastatin was associated with higher rates of trigger finger, elbow tendinopathies, and shoulder tendinopathies, but not significantly with De Quervain’s or Achilles tendinopathy. The remaining statins, grouped together, also showed elevated rates. The risk appears to be a class-wide effect rather than limited to one or two drugs.
Does the Risk Increase the Longer You Take Statins?
Interestingly, the highest risk occurs early. Risk was elevated 134% in the first three months and 121% between three and six months. After six months of continuous use the excess risk fell to only 12%. For several specific tendinopathies (De Quervain’s, elbow, and Achilles), rates were no longer significantly different from non-users after the six-month mark.
This suggests the initial period of statin use is the highest-risk window. Patients who tolerate a statin for six months without tendon problems are unlikely to face substantially elevated risk thereafter.
Why Metabolic Health Matters for Tendons
Statin use is only one piece of the picture. Poor metabolic health is itself a strong independent risk factor for tendon injury. Data from the Copenhagen City Heart Study showed that metabolic syndrome was associated with approximately 2.5 times higher risk of tendon injury. Elevated hemoglobin A1c carried a 3-fold higher risk, and high cholesterol a 1.5-fold higher risk.
In practice I increasingly view many chronic or recurrent tendinopathies as having a significant metabolic component. Addressing insulin resistance, body composition, and systemic inflammation is often essential for durable improvement.
How to Protect Your Tendons and Improve Metabolic Health
Whether or not you take a statin, the following strategies reduce tendon risk and support overall health:
• Prioritize an anti-inflammatory diet rich in vegetables, fruits, lean proteins, nuts, seeds, legumes, and omega-3 sources while minimizing processed foods, refined carbohydrates, and sugary drinks.
• Perform at least 30 minutes of moderate aerobic exercise most days of the week.
• Include strength training at least three times per week. Progressive loading improves tendon capacity and insulin sensitivity.
Should You Stop Your Statin?
This decision must be individualized. For patients with established cardiovascular disease or major risk factors (prior heart attack, stroke, diabetes), the life-saving benefits of statins almost always outweigh the modest increase in tendinopathy risk. Never stop a statin on your own.
If you are experiencing tendon pain while on a statin, discuss the symptoms with your physician. Options may include dose adjustment, switching agents, or intensified focus on metabolic and loading strategies. You can also schedule a consultation to evaluate the tendon problem itself and build a comprehensive plan.
References
1. Kwak D, Moon SJ, Park JW, Lee DH, Lee JI. Effects of Statin Treatment on the Development of Tendinopathy: A Nationwide Population-Based Cohort Study. Orthop J Sports Med. 2023;11(7):23259671231167851. doi:10.1177/23259671231167851
2. Skovgaard D, Siersma VD, Klausen SB, et al. Chronic hyperglycemia, hypercholesterolemia, and metabolic syndrome are associated with risk of tendon injury. Scand J Med Sci Sports. 2021;31(9):1822-1831. doi:10.1111/sms.13984
Medical Disclaimer: This content is for educational purposes only and does not substitute for the medical advice of a physician. Always consult your healthcare provider before beginning any new treatment program. The information presented reflects the opinion of Dr. Jeffrey Peng and does not represent the views of his employers or affiliated hospital systems.
Comments